OPRM1 and adenocarcinoma: In 2011, Liu et al. explored the efficacy of tramadol/paracetamol combination in 96 Chinese patients with adenocarcinoma of the colon, rectum, or stomach and the OPRM1 A118G (rs1799971) polymorphism [29].